Global Rapid Diagnostic Testing for Influenza Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 46293
  • calendar_today Published On: Mar, 2021
  • file_copy Pages: 156
  • list Medical Devices
Buy @ $3500

The Rapid Diagnostic Testing for Influenza market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Rapid Diagnostic Testing for Influenza size is estimated to be USD 1520.9 million in 2026 from USD 1094.4 million in 2020, with a change XX% between 2020 and 2021. The global Rapid Diagnostic Testing for Influenza market size is expected to grow at a CAGR of 8.6% for the next five years.

Market segmentation

Rapid Diagnostic Testing for Influenza market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Digital RIDTs

Conventional RIDT

Market segment by Application, can be divided into

Hospitals

POCT

Others

Market segment by players, this report covers

BD

Abbot (Alere)

Quidel

Roche

Thermo Fisher Scientific

Meridian Bioscience

Analytik Jena

Princeton BioMeditech Corporation

BioMerieux

Sekisui Diagnostics

Response Biomedical

SA Scientific

DiaSorin (Focus Diagnostics)

Wondfo

Beijing Wantai Biological Pharmacy

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Rapid Diagnostic Testing for Influenza

1.2 Classification of Rapid Diagnostic Testing for Influenza by Type

1.2.1 Overview: Global Rapid Diagnostic Testing for Influenza Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Type in 2020

1.2.3 Digital RIDTs

1.2.4 Conventional RIDT

1.3 Global Rapid Diagnostic Testing for Influenza Market by Application

1.3.1 Overview: Global Rapid Diagnostic Testing for Influenza Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Hospitals

1.3.3 POCT

1.3.4 Others

1.4 Global Rapid Diagnostic Testing for Influenza Market Size & Forecast

1.5 Global Rapid Diagnostic Testing for Influenza Market Size and Forecast by Region

1.5.1 Global Rapid Diagnostic Testing for Influenza Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Rapid Diagnostic Testing for Influenza Market Size by Region, (2016-2021)

1.5.3 North America Rapid Diagnostic Testing for Influenza Market Size and Prospect (2016-2026)

1.5.4 Europe Rapid Diagnostic Testing for Influenza Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size and Prospect (2016-2026)

1.5.6 South America Rapid Diagnostic Testing for Influenza Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Rapid Diagnostic Testing for Influenza Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Rapid Diagnostic Testing for Influenza Market Drivers

1.6.2 Rapid Diagnostic Testing for Influenza Market Restraints

1.6.3 Rapid Diagnostic Testing for Influenza Trends Analysis

2 Company Profiles

2.1 BD

2.1.1 BD Details

2.1.2 BD Major Business

2.1.3 BD Rapid Diagnostic Testing for Influenza Product and Solutions

2.1.4 BD Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 BD Recent Developments and Future Plans

2.2 Abbot (Alere)

2.2.1 Abbot (Alere) Details

2.2.2 Abbot (Alere) Major Business

2.2.3 Abbot (Alere) Rapid Diagnostic Testing for Influenza Product and Solutions

2.2.4 Abbot (Alere) Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Abbot (Alere) Recent Developments and Future Plans

2.3 Quidel

2.3.1 Quidel Details

2.3.2 Quidel Major Business

2.3.3 Quidel Rapid Diagnostic Testing for Influenza Product and Solutions

2.3.4 Quidel Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Quidel Recent Developments and Future Plans

2.4 Roche

2.4.1 Roche Details

2.4.2 Roche Major Business

2.4.3 Roche Rapid Diagnostic Testing for Influenza Product and Solutions

2.4.4 Roche Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Roche Recent Developments and Future Plans

2.5 Thermo Fisher Scientific

2.5.1 Thermo Fisher Scientific Details

2.5.2 Thermo Fisher Scientific Major Business

2.5.3 Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Product and Solutions

2.5.4 Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Thermo Fisher Scientific Recent Developments and Future Plans

2.6 Meridian Bioscience

2.6.1 Meridian Bioscience Details

2.6.2 Meridian Bioscience Major Business

2.6.3 Meridian Bioscience Rapid Diagnostic Testing for Influenza Product and Solutions

2.6.4 Meridian Bioscience Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Meridian Bioscience Recent Developments and Future Plans

2.7 Analytik Jena

2.7.1 Analytik Jena Details

2.7.2 Analytik Jena Major Business

2.7.3 Analytik Jena Rapid Diagnostic Testing for Influenza Product and Solutions

2.7.4 Analytik Jena Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Analytik Jena Recent Developments and Future Plans

2.8 Princeton BioMeditech Corporation

2.8.1 Princeton BioMeditech Corporation Details

2.8.2 Princeton BioMeditech Corporation Major Business

2.8.3 Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Product and Solutions

2.8.4 Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Princeton BioMeditech Corporation Recent Developments and Future Plans

2.9 BioMerieux

2.9.1 BioMerieux Details

2.9.2 BioMerieux Major Business

2.9.3 BioMerieux Rapid Diagnostic Testing for Influenza Product and Solutions

2.9.4 BioMerieux Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 BioMerieux Recent Developments and Future Plans

2.10 Sekisui Diagnostics

2.10.1 Sekisui Diagnostics Details

2.10.2 Sekisui Diagnostics Major Business

2.10.3 Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Product and Solutions

2.10.4 Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Sekisui Diagnostics Recent Developments and Future Plans

2.11 Response Biomedical

2.11.1 Response Biomedical Details

2.11.2 Response Biomedical Major Business

2.11.3 Response Biomedical Rapid Diagnostic Testing for Influenza Product and Solutions

2.11.4 Response Biomedical Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Response Biomedical Recent Developments and Future Plans

2.12 SA Scientific

2.12.1 SA Scientific Details

2.12.2 SA Scientific Major Business

2.12.3 SA Scientific Rapid Diagnostic Testing for Influenza Product and Solutions

2.12.4 SA Scientific Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 SA Scientific Recent Developments and Future Plans

2.13 DiaSorin (Focus Diagnostics)

2.13.1 DiaSorin (Focus Diagnostics) Details

2.13.2 DiaSorin (Focus Diagnostics) Major Business

2.13.3 DiaSorin (Focus Diagnostics) Rapid Diagnostic Testing for Influenza Product and Solutions

2.13.4 DiaSorin (Focus Diagnostics) Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 DiaSorin (Focus Diagnostics) Recent Developments and Future Plans

2.14 Wondfo

2.14.1 Wondfo Details

2.14.2 Wondfo Major Business

2.14.3 Wondfo Rapid Diagnostic Testing for Influenza Product and Solutions

2.14.4 Wondfo Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Wondfo Recent Developments and Future Plans

2.15 Beijing Wantai Biological Pharmacy

2.15.1 Beijing Wantai Biological Pharmacy Details

2.15.2 Beijing Wantai Biological Pharmacy Major Business

2.15.3 Beijing Wantai Biological Pharmacy Rapid Diagnostic Testing for Influenza Product and Solutions

2.15.4 Beijing Wantai Biological Pharmacy Rapid Diagnostic Testing for Influenza Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Beijing Wantai Biological Pharmacy Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Rapid Diagnostic Testing for Influenza Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Rapid Diagnostic Testing for Influenza Players Market Share

3.2.2 Top 10 Rapid Diagnostic Testing for Influenza Players Market Share

3.2.3 Market Competition Trend

3.3 Rapid Diagnostic Testing for Influenza Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Rapid Diagnostic Testing for Influenza Revenue and Market Share by Type (2016-2021)

4.2 Global Rapid Diagnostic Testing for Influenza Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Application (2016-2021)

5.2 Rapid Diagnostic Testing for Influenza Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Rapid Diagnostic Testing for Influenza Revenue by Type (2016-2026)

6.2 North America Rapid Diagnostic Testing for Influenza Revenue by Application (2016-2026)

6.3 North America Rapid Diagnostic Testing for Influenza Market Size by Country

6.3.1 North America Rapid Diagnostic Testing for Influenza Revenue by Country (2016-2026)

6.3.2 United States Rapid Diagnostic Testing for Influenza Market Size and Forecast (2016-2026)

6.3.3 Canada Rapid Diagnostic Testing for Influenza Market Size and Forecast (2016-2026)

6.3.4 Mexico Rapid Diagnostic Testing for Influenza Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Rapid Diagnostic Testing for Influenza Revenue by Type (2016-2026)

7.2 Europe Rapid Diagnostic Testing for Influenza Revenue by Application (2016-2026)

7.3 Europe Rapid Diagnostic Testing for Influenza Market Size by Country

7.3.1 Europe Rapid Diagnostic Testing for Influenza Revenue by Country (2016-2026)

7.3.2 Germany Rapid Diagnostic Testing for Influenza Market Size and Forecast (2016-2026)

7.3.3 France Rapid Diagnostic Testing for Influenza Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Rapid Diagnostic Testing for Influenza Market Size and Forecast (2016-2026)

7.3.5 Russia Rapid Diagnostic Testing for Influenza Market Size and Forecast (2016-2026)

7.3.6 Italy Rapid Diagnostic Testing for Influenza Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Rapid Diagnostic Testing for Influenza Revenue by Type (2016-2026)

8.2 Asia-Pacific Rapid Diagnostic Testing for Influenza Revenue by Application (2016-2026)

8.3 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Region

8.3.1 Asia-Pacific Rapid Diagnostic Testing for Influenza Revenue by Region (2016-2026)

8.3.2 China Rapid Diagnostic Testing for Influenza Market Size and Forecast (2016-2026)

8.3.3 Japan Rapid Diagnostic Testing for Influenza Market Size and Forecast (2016-2026)

8.3.4 South Korea Rapid Diagnostic Testing for Influenza Market Size and Forecast (2016-2026)

8.3.5 India Rapid Diagnostic Testing for Influenza Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Rapid Diagnostic Testing for Influenza Market Size and Forecast (2016-2026)

8.3.7 Australia Rapid Diagnostic Testing for Influenza Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Rapid Diagnostic Testing for Influenza Revenue by Type (2016-2026)

9.2 South America Rapid Diagnostic Testing for Influenza Revenue by Application (2016-2026)

9.3 South America Rapid Diagnostic Testing for Influenza Market Size by Country

9.3.1 South America Rapid Diagnostic Testing for Influenza Revenue by Country (2016-2026)

9.3.2 Brazil Rapid Diagnostic Testing for Influenza Market Size and Forecast (2016-2026)

9.3.3 Argentina Rapid Diagnostic Testing for Influenza Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Rapid Diagnostic Testing for Influenza Revenue by Type (2016-2026)

10.2 Middle East & Africa Rapid Diagnostic Testing for Influenza Revenue by Application (2016-2026)

10.3 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Country

10.3.1 Middle East & Africa Rapid Diagnostic Testing for Influenza Revenue by Country (2016-2026)

10.3.2 Turkey Rapid Diagnostic Testing for Influenza Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Rapid Diagnostic Testing for Influenza Market Size and Forecast (2016-2026)

10.3.4 UAE Rapid Diagnostic Testing for Influenza Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Rapid Diagnostic Testing for Influenza Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Rapid Diagnostic Testing for Influenza Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Rapid Diagnostic Testing for Influenza Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Rapid Diagnostic Testing for Influenza Revenue (USD Million) by Region (2016-2021)

Table 5. Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Region (2021-2026)

Table 6. BD Corporate Information, Head Office, and Major Competitors

Table 7. BD Major Business

Table 8. BD Rapid Diagnostic Testing for Influenza Product and Solutions

Table 9. BD Rapid Diagnostic Testing for Influenza Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Abbot (Alere) Corporate Information, Head Office, and Major Competitors

Table 11. Abbot (Alere) Major Business

Table 12. Abbot (Alere) Rapid Diagnostic Testing for Influenza Product and Solutions

Table 13. Abbot (Alere) Rapid Diagnostic Testing for Influenza Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Quidel Corporate Information, Head Office, and Major Competitors

Table 15. Quidel Major Business

Table 16. Quidel Rapid Diagnostic Testing for Influenza Product and Solutions

Table 17. Quidel Rapid Diagnostic Testing for Influenza Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Roche Corporate Information, Head Office, and Major Competitors

Table 19. Roche Major Business

Table 20. Roche Rapid Diagnostic Testing for Influenza Product and Solutions

Table 21. Roche Rapid Diagnostic Testing for Influenza Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors

Table 23. Thermo Fisher Scientific Major Business

Table 24. Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Product and Solutions

Table 25. Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Meridian Bioscience Corporate Information, Head Office, and Major Competitors

Table 27. Meridian Bioscience Major Business

Table 28. Meridian Bioscience Rapid Diagnostic Testing for Influenza Product and Solutions

Table 29. Meridian Bioscience Rapid Diagnostic Testing for Influenza Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Analytik Jena Corporate Information, Head Office, and Major Competitors

Table 31. Analytik Jena Major Business

Table 32. Analytik Jena Rapid Diagnostic Testing for Influenza Product and Solutions

Table 33. Analytik Jena Rapid Diagnostic Testing for Influenza Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Princeton BioMeditech Corporation Corporate Information, Head Office, and Major Competitors

Table 35. Princeton BioMeditech Corporation Major Business

Table 36. Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Product and Solutions

Table 37. Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. BioMerieux Corporate Information, Head Office, and Major Competitors

Table 39. BioMerieux Major Business

Table 40. BioMerieux Rapid Diagnostic Testing for Influenza Product and Solutions

Table 41. BioMerieux Rapid Diagnostic Testing for Influenza Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Sekisui Diagnostics Corporate Information, Head Office, and Major Competitors

Table 43. Sekisui Diagnostics Major Business

Table 44. Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Product and Solutions

Table 45. Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Response Biomedical Corporate Information, Head Office, and Major Competitors

Table 47. Response Biomedical Major Business

Table 48. Response Biomedical Rapid Diagnostic Testing for Influenza Product and Solutions

Table 49. Response Biomedical Rapid Diagnostic Testing for Influenza Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. SA Scientific Corporate Information, Head Office, and Major Competitors

Table 51. SA Scientific Major Business

Table 52. SA Scientific Rapid Diagnostic Testing for Influenza Product and Solutions

Table 53. SA Scientific Rapid Diagnostic Testing for Influenza Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. DiaSorin (Focus Diagnostics) Corporate Information, Head Office, and Major Competitors

Table 55. DiaSorin (Focus Diagnostics) Major Business

Table 56. DiaSorin (Focus Diagnostics) Rapid Diagnostic Testing for Influenza Product and Solutions

Table 57. DiaSorin (Focus Diagnostics) Rapid Diagnostic Testing for Influenza Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Wondfo Corporate Information, Head Office, and Major Competitors

Table 59. Wondfo Major Business

Table 60. Wondfo Rapid Diagnostic Testing for Influenza Product and Solutions

Table 61. Wondfo Rapid Diagnostic Testing for Influenza Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Beijing Wantai Biological Pharmacy Corporate Information, Head Office, and Major Competitors

Table 63. Beijing Wantai Biological Pharmacy Major Business

Table 64. Beijing Wantai Biological Pharmacy Rapid Diagnostic Testing for Influenza Product and Solutions

Table 65. Beijing Wantai Biological Pharmacy Rapid Diagnostic Testing for Influenza Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Global Rapid Diagnostic Testing for Influenza Revenue (USD Million) by Players (2019-2021)

Table 67. Global Rapid Diagnostic Testing for Influenza Revenue Share by Players (2019-2021)

Table 68. Breakdown of Rapid Diagnostic Testing for Influenza by Company Type (Tier 1, Tier 2 and Tier 3)

Table 69. Rapid Diagnostic Testing for Influenza Players Head Office, Products and Services Provided

Table 70. Rapid Diagnostic Testing for Influenza Mergers & Acquisitions in the Past Five Years

Table 71. Rapid Diagnostic Testing for Influenza New Entrants and Expansion Plans

Table 72. Global Rapid Diagnostic Testing for Influenza Revenue (USD Million) by Type (2016-2021)

Table 73. Global Rapid Diagnostic Testing for Influenza Revenue Share by Type (2016-2021)

Table 74. Global Rapid Diagnostic Testing for Influenza Revenue Forecast by Type (2021-2026)

Table 75. Global Rapid Diagnostic Testing for Influenza Revenue by Application (2016-2021)

Table 76. Global Rapid Diagnostic Testing for Influenza Revenue Forecast by Application (2021-2026)

Table 77. North America Rapid Diagnostic Testing for Influenza Revenue by Type (2016-2021) & (USD Million)

Table 78. North America Rapid Diagnostic Testing for Influenza Revenue by Type (2021-2026) & (USD Million)

Table 79. North America Rapid Diagnostic Testing for Influenza Revenue by Application (2016-2021) & (USD Million)

Table 80. North America Rapid Diagnostic Testing for Influenza Revenue by Application (2021-2026) & (USD Million)

Table 81. North America Rapid Diagnostic Testing for Influenza Revenue by Country (2016-2021) & (USD Million)

Table 82. North America Rapid Diagnostic Testing for Influenza Revenue by Country (2021-2026) & (USD Million)

Table 83. Europe Rapid Diagnostic Testing for Influenza Revenue by Type (2016-2021) & (USD Million)

Table 84. Europe Rapid Diagnostic Testing for Influenza Revenue by Type (2021-2026) & (USD Million)

Table 85. Europe Rapid Diagnostic Testing for Influenza Revenue by Application (2016-2021) & (USD Million)

Table 86. Europe Rapid Diagnostic Testing for Influenza Revenue by Application (2021-2026) & (USD Million)

Table 87. Europe Rapid Diagnostic Testing for Influenza Revenue by Country (2016-2021) & (USD Million)

Table 88. Europe Rapid Diagnostic Testing for Influenza Revenue by Country (2021-2026) & (USD Million)

Table 89. Asia-Pacific Rapid Diagnostic Testing for Influenza Revenue by Type (2016-2021) & (USD Million)

Table 90. Asia-Pacific Rapid Diagnostic Testing for Influenza Revenue by Type (2021-2026) & (USD Million)

Table 91. Asia-Pacific Rapid Diagnostic Testing for Influenza Revenue by Application (2016-2021) & (USD Million)

Table 92. Asia-Pacific Rapid Diagnostic Testing for Influenza Revenue by Application (2021-2026) & (USD Million)

Table 93. Asia-Pacific Rapid Diagnostic Testing for Influenza Revenue by Region (2016-2021) & (USD Million)

Table 94. Asia-Pacific Rapid Diagnostic Testing for Influenza Revenue by Region (2021-2026) & (USD Million)

Table 95. South America Rapid Diagnostic Testing for Influenza Revenue by Type (2016-2021) & (USD Million)

Table 96. South America Rapid Diagnostic Testing for Influenza Revenue by Type (2021-2026) & (USD Million)

Table 97. South America Rapid Diagnostic Testing for Influenza Revenue by Application (2016-2021) & (USD Million)

Table 98. South America Rapid Diagnostic Testing for Influenza Revenue by Application (2021-2026) & (USD Million)

Table 99. South America Rapid Diagnostic Testing for Influenza Revenue by Country (2016-2021) & (USD Million)

Table 100. South America Rapid Diagnostic Testing for Influenza Revenue by Country (2021-2026) & (USD Million)

Table 101. Middle East & Africa Rapid Diagnostic Testing for Influenza Revenue by Type (2016-2021) & (USD Million)

Table 102. Middle East & Africa Rapid Diagnostic Testing for Influenza Revenue by Type (2021-2026) & (USD Million)

Table 103. Middle East & Africa Rapid Diagnostic Testing for Influenza Revenue by Application (2016-2021) & (USD Million)

Table 104. Middle East & Africa Rapid Diagnostic Testing for Influenza Revenue by Application (2021-2026) & (USD Million)

Table 105. Middle East & Africa Rapid Diagnostic Testing for Influenza Revenue by Country (2016-2021) & (USD Million)

Table 106. Middle East & Africa Rapid Diagnostic Testing for Influenza Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Rapid Diagnostic Testing for Influenza Picture

Figure 2. Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Type in 2020

Figure 3. Digital RIDTs

Figure 4. Conventional RIDT

Figure 5. Rapid Diagnostic Testing for Influenza Revenue Market Share by Application in 2020

Figure 6. Hospitals Picture

Figure 7. POCT Picture

Figure 8. Others Picture

Figure 9. Global Rapid Diagnostic Testing for Influenza Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 10. Global Rapid Diagnostic Testing for Influenza Revenue and Forecast (2016-2026) & (USD Million)

Figure 11. Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Region (2016-2026)

Figure 12. Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Region in 2020

Figure 13. North America Rapid Diagnostic Testing for Influenza Revenue (USD Million) and Growth Rate (2016-2026)

Figure 14. Europe Rapid Diagnostic Testing for Influenza Revenue (USD Million) and Growth Rate (2016-2026)

Figure 15. Asia-Pacific Rapid Diagnostic Testing for Influenza Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. South America Rapid Diagnostic Testing for Influenza Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Middle East and Africa Rapid Diagnostic Testing for Influenza Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Rapid Diagnostic Testing for Influenza Market Drivers

Figure 19. Rapid Diagnostic Testing for Influenza Market Restraints

Figure 20. Rapid Diagnostic Testing for Influenza Market Trends

Figure 21. BD Recent Developments and Future Plans

Figure 22. Abbot (Alere) Recent Developments and Future Plans

Figure 23. Quidel Recent Developments and Future Plans

Figure 24. Roche Recent Developments and Future Plans

Figure 25. Thermo Fisher Scientific Recent Developments and Future Plans

Figure 26. Meridian Bioscience Recent Developments and Future Plans

Figure 27. Analytik Jena Recent Developments and Future Plans

Figure 28. Princeton BioMeditech Corporation Recent Developments and Future Plans

Figure 29. BioMerieux Recent Developments and Future Plans

Figure 30. Sekisui Diagnostics Recent Developments and Future Plans

Figure 31. Response Biomedical Recent Developments and Future Plans

Figure 32. SA Scientific Recent Developments and Future Plans

Figure 33. DiaSorin (Focus Diagnostics) Recent Developments and Future Plans

Figure 34. Wondfo Recent Developments and Future Plans

Figure 35. Beijing Wantai Biological Pharmacy Recent Developments and Future Plans

Figure 36. Global Rapid Diagnostic Testing for Influenza Revenue Share by Players in 2020

Figure 37. Rapid Diagnostic Testing for Influenza Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 38. Global Top 3 Players Rapid Diagnostic Testing for Influenza Revenue Market Share in 2020

Figure 39. Global Top 10 Players Rapid Diagnostic Testing for Influenza Revenue Market Share in 2020

Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 41. Global Rapid Diagnostic Testing for Influenza Revenue Share by Type in 2020

Figure 42. Global Rapid Diagnostic Testing for Influenza Market Share Forecast by Type (2021-2026)

Figure 43. Global Rapid Diagnostic Testing for Influenza Revenue Share by Application in 2020

Figure 44. Global Rapid Diagnostic Testing for Influenza Market Share Forecast by Application (2021-2026)

Figure 45. North America Rapid Diagnostic Testing for Influenza Sales Market Share by Type (2016-2026)

Figure 46. North America Rapid Diagnostic Testing for Influenza Sales Market Share by Application (2016-2026)

Figure 47. North America Rapid Diagnostic Testing for Influenza Revenue Market Share by Country (2016-2026)

Figure 48. United States Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. Canada Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Mexico Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Europe Rapid Diagnostic Testing for Influenza Sales Market Share by Type (2016-2026)

Figure 52. Europe Rapid Diagnostic Testing for Influenza Sales Market Share by Application (2016-2026)

Figure 53. Europe Rapid Diagnostic Testing for Influenza Revenue Market Share by Country (2016-2026)

Figure 54. Germany Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. France Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. United Kingdom Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Russia Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Italy Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Asia-Pacific Rapid Diagnostic Testing for Influenza Sales Market Share by Type (2016-2026)

Figure 60. Asia-Pacific Rapid Diagnostic Testing for Influenza Sales Market Share by Application (2016-2026)

Figure 61. Asia-Pacific Rapid Diagnostic Testing for Influenza Revenue Market Share by Region (2016-2026)

Figure 62. China Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Japan Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. South Korea Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. India Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Southeast Asia Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Australia Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. South America Rapid Diagnostic Testing for Influenza Sales Market Share by Type (2016-2026)

Figure 69. South America Rapid Diagnostic Testing for Influenza Sales Market Share by Application (2016-2026)

Figure 70. South America Rapid Diagnostic Testing for Influenza Revenue Market Share by Country (2016-2026)

Figure 71. Brazil Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Argentina Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Middle East and Africa Rapid Diagnostic Testing for Influenza Sales Market Share by Type (2016-2026)

Figure 74. Middle East and Africa Rapid Diagnostic Testing for Influenza Sales Market Share by Application (2016-2026)

Figure 75. Middle East and Africa Rapid Diagnostic Testing for Influenza Revenue Market Share by Country (2016-2026)

Figure 76. Turkey Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Saudi Arabia Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. UAE Rapid Diagnostic Testing for Influenza Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. Methodology

Figure 80. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

+1

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketquest.biz